March/April 2000

Vol 7, No 2 CME Pretest

This Journal provides 4 hours of Category 1 Continuing Medical Education

Complimentary CME Credits

Physicians can earn 4 credit hours of Category 1 for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions in the posttest at the end of this issue. Complete instructions are given on the posttest pages. Successfully answering 30 or more questions will earn 4 credit hours. CME is presented by an unrestricted educational grant from Bristol-Myers Squibb Oncology Division.

Educational Objectives

After reading this issue of Cancer Control, clinicians will be expected to:

• know the pharmacokinetics of various routes of opioid delivery,
• understand the role of neurolytic blocks for relieving visceral cancer pain,
• identify nonpharmaceutical approaches to relieve cancer pain, and
• be aware of the advances in biochemotherapy for malignant melanoma.

This program was planned in accordance with ACCME Essentials.

Release Date: March 1, 2000
Expiration Date: March 1, 2001

Pretest

1. Nonsteroidal anti-inflammatory drugs (NSAIDs) are particularly useful for which type of pain?

a. visceral pain

b. referred pain

c. bone pain

d. neuropathic pain

2. Which class of interventions should be avoided when treating constipation due to opioid analgesia?

a. bowel stimulants

b. stool softeners

c. oral hydration

d. bulking agents

3. What is the expected incidence of complete remissions in patients with metastatic melanoma treated with conventional single-agent chemotherapy?

a. <5%

b. 10% - 15%

c. 20% - 30%

d. 40% - 50%